California Public Employees Retirement System Has $2.84 Million Position in Omnicell, Inc. (NASDAQ:OMCL)

California Public Employees Retirement System lifted its stake in Omnicell, Inc. (NASDAQ:OMCL) by 11.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 75,523 shares of the company’s stock after acquiring an additional 7,902 shares during the quarter. California Public Employees Retirement System owned approximately 0.17% of Omnicell worth $2,842,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Avory & Company LLC boosted its holdings in Omnicell by 22.7% in the third quarter. Avory & Company LLC now owns 153,776 shares of the company’s stock worth $6,926,000 after purchasing an additional 28,416 shares in the last quarter. Vanguard Group Inc. boosted its stake in shares of Omnicell by 15.1% during the 3rd quarter. Vanguard Group Inc. now owns 5,137,084 shares of the company’s stock worth $231,374,000 after acquiring an additional 674,824 shares in the last quarter. Pacer Advisors Inc. increased its holdings in shares of Omnicell by 321,488.8% during the 4th quarter. Pacer Advisors Inc. now owns 1,058,027 shares of the company’s stock valued at $39,814,000 after acquiring an additional 1,057,698 shares during the last quarter. Public Sector Pension Investment Board bought a new position in shares of Omnicell in the 3rd quarter valued at approximately $2,517,000. Finally, Ontario Teachers Pension Plan Board acquired a new stake in Omnicell in the 3rd quarter worth approximately $984,000. 97.70% of the stock is currently owned by hedge funds and other institutional investors.

Omnicell Trading Up 2.9 %

Shares of Omnicell stock opened at $30.13 on Monday. Omnicell, Inc. has a 1 year low of $25.69 and a 1 year high of $77.14. The company’s fifty day simple moving average is $27.73 and its 200-day simple moving average is $31.66. The company has a market cap of $1.38 billion, a price-to-earnings ratio of -65.50 and a beta of 0.77. The company has a current ratio of 2.38, a quick ratio of 2.22 and a debt-to-equity ratio of 0.48.

Omnicell (NASDAQ:OMCL) last posted its quarterly earnings results on Thursday, February 8th. The company reported $0.12 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.10) by $0.22. Omnicell had a negative net margin of 1.91% and a positive return on equity of 2.41%. The company had revenue of $258.85 million for the quarter, compared to analyst estimates of $256.00 million. As a group, sell-side analysts expect that Omnicell, Inc. will post 0.09 EPS for the current year.

Analyst Ratings Changes

OMCL has been the topic of a number of recent analyst reports. Wells Fargo & Company dropped their price target on shares of Omnicell from $28.00 to $26.00 and set an “equal weight” rating on the stock in a research report on Friday, February 9th. Benchmark reissued a “buy” rating and set a $38.00 target price on shares of Omnicell in a research report on Tuesday, April 30th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $42.20.

About Omnicell

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.